You just read:

Lumena Pharmaceuticals Launches Global Clinical Program to Evaluate Safety and Efficacy of LUM001 in Children with Alagille Syndrome

News provided by

Lumena Pharmaceuticals

26 Sep, 2013, 13:00 BST